CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination
Palabras clave :
Angiogenesis Inhibitors/physiology
CD4-Positive T-Lymphocytes/immunology
Colonic Neoplasms/immunology
Down-Regulation/immunology
Interferon-gamma/physiology
Lymphocyte Activation/immunology
Peptides/immunology
Receptors, Interleukin-2/biosynthesis
T-Lymphocyte Subsets/immunology
Fecha de publicación :
2003
Editorial :
American Association of Immunologists
Cita:
Casares N, Arribillaga L, Sarobe P, Dotor J, Lopez-Diaz de Cerio A, Melero I, et al. CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination. J Immunol 2003 Dec 1;171(11):5931-5939.
Aparece en las colecciones:
Estadísticas e impacto
0 citas en
0 citas en
Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.